The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 29, 2025

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between November 2,